Related Experiment Video
Updated: Mar 24, 2026
Modification and Functionalization of the Guanidine Group by Tailor-made Precursors
Published on: April 27, 2017
Preliminary in vitro evaluation of the anti-proliferative activity of guanylhydrazone derivatives
Abstract:
Guanylhydrazones have shown promising antitumor activity in preclinical tumor models in several studies. In this study, we aimed at evaluating the cytotoxic effect of a series of synthetic guanylhydrazones. Different human tumor cell lines, by including HCT-8 (colon carcinoma), MDA-MB-435 (melanoma) and SF-295 (glioblastoma) were continuous exposed to guanylhydrazone derivatives for 72 hours and growth inhibition of tumor cell lines and macrophages J774 was measured using tetrazolium salt (MTT) assay. Compounds 7, 11, 16 and 17 showed strong cytotoxic activity with IC50 values lower than 10 μmol L(-1) against four tumor cell lines. Among them, 7 was less toxic to non-tumor cells. Finally, obtained data suggest that guanylhydrazones may be regarded as potential lead compounds for the design of novel anticancer agents.
Insights
Synthetic guanylhydrazones show significant anticancer potential. Certain compounds demonstrated strong cytotoxic effects against colon carcinoma, melanoma, and glioblastoma cell lines, with one compound exhibiting lower toxicity to non-tumor cells.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Oncology
Background:
- Guanylhydrazones have demonstrated promising preclinical antitumor activity.
- Further investigation is needed to evaluate their cytotoxic effects and potential as anticancer agents.
Purpose of the Study:
- To evaluate the cytotoxic effect of synthetic guanylhydrazone derivatives.
- To identify potent guanylhydrazones with selective toxicity against human tumor cell lines.
Main Methods:
- Exposure of human tumor cell lines (HCT-8, MDA-MB-435, SF-295) and macrophages (J774) to guanylhydrazone derivatives for 72 hours.
- Measurement of growth inhibition using the tetrazolium salt (MTT) assay.
- Determination of half-maximal inhibitory concentration (IC50) values.
Main Results:
- Compounds 7, 11, 16, and 17 exhibited strong cytotoxic activity against tumor cell lines, with IC50 values below 10 μmol/L.
- Compound 7 displayed reduced toxicity towards non-tumor cells (macrophages).
- Significant growth inhibition was observed in colon carcinoma, melanoma, and glioblastoma cell lines.
Conclusions:
- Synthetic guanylhydrazones possess significant cytotoxic potential against various human tumor cell lines.
- Compound 7 is a promising candidate due to its potent antitumor activity and lower toxicity to normal cells.
- Guanylhydrazones represent potential lead compounds for the development of novel anticancer therapeutics.
